Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M: A modified microtiter-plate test for Cell Cycle inhibitor quantification of staphylococcal biofilm formation. J Microbiol Methods 2000, 40:175–179.PubMedCrossRef 48. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J: The epidemic

of antibiotic-resistant infections: a call to action for the medical community from the infectious diseases society of America. Clin Infect Dis 2008, 46:155–164.PubMedCrossRef 49. CLSI: Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute; 2008. 50. CLSI: Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria EX 527 in vitro isolated from animals. In M31-A. Wayne, PA; 2008. 51. Gilbert P, Allison DG, McBain AJ: Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance? Symp Ser Soc Appl Microbiol 2002, 292:98–110.CrossRef 52. Nienhoff U, Kadlec K, Chaberny IF, Verspohl J, Gerlach GF, Kreienbrock L, Schwarz S, Simon D, Nolte I: Methicillin-resistant Staphylococcus pseudintermedius among dogs admitted to a small animal hospital. Vet Microbiol 2011, 150:191–197.PubMedCrossRef 53. Cordaro JC,

Melton T, Stratis JP, Atagun M, Gladding C, Hartman Interleukin-2 receptor PE, Roseman S: Fosfomycin resistance: selection method for internal and extended deletions of the phosphoenolpyruvate:sugar phosphotransferase genes of Salmonella typhimurium . J Bacteriol 1976, 128:785–793.PubMedCentralPubMed 54. Gomez-Sanz E, Torres C, Benito D, Lozano C, Zarazaga

M: Animal and human staphylococcus aureus associated clonal lineages and high rate of Staphylococcus pseudintermedius novel lineages in Spanish kennel dogs: Predominance of S. aureus ST398. Vet Microbiol 2013, 166:580–589.PubMedCrossRef 55. Thauvin C, Lemeland JF, Humbert G, Fillastre JP: Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother 1988, 32:919–921.PubMedCentralPubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions MD designed experiments, and carried out micro-titre plate assays, SEM imaging and determined MIC assays, and prepared and drafted the manuscript. SN, and SW conceived the study. SN, SW and AM participated in the design and implementation and reviewed the manuscript. All authors read and approved the final manuscript.”
“Background Mycobacterium MK5108 datasheet tuberculosis (Mtb), the causative agent of tuberculosis, carries different virulence factors, which allow proliferation of the pathogen in the host cell, cell-to-cell spread, and evasion of immune response.